The United States has revoked and denied visas to certain Indian business executives for their alleged involvement in trafficking fentanyl precursors, as announced by the US embassy in New Delhi. While the identities of those affected were not disclosed, the embassy emphasized its commitment to combatting illicit drug trafficking, a priority amid rising fentanyl-related overdose deaths in the US. The embassy lauded cooperation with the Indian government in addressing this transnational challenge, highlighting the need for joint efforts to ensure public safety. This development underscores the growing scrutiny on international drug trafficking and the importance of bilateral collaboration in tackling such issues that threaten both nations.